Skip to content

A randomized controlled trial for improving QOL(quality-of-life) concerning knee joint in human

A randomized controlled trial for improving QOL(quality-of-life) concerning knee joint in human - A randomized controlled trial for improving QOL(quality-of-life) concerning knee joint in human

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014652
Enrollment
45
Registered
2014-07-27
Start date
2014-07-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

SAMe yeast: 0mg/day Duration: 12weeks SAMe yeast: 500mg/day Duration: 12weeks SAMe yeast: 2500mg/day Duration: 12weeks

Sponsors

CPCC Company Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Males and females aged 50 to 74 years old (2)Subjects who feel discomfort and/or pain on knee joint within the last 6 month, and the discomfort and/or pain are still continuing

Exclusion criteria

Exclusion criteria: (1)Patients being treated for rheumatoid arthritis (2)Subjects who have a weak stomach, be suspected of gastrointestinal disease and/or have diarrhea routinely (3)Subjects who have previous medical history and/or current medical history of serious diseases (e.g., heart, liver, kidney, pancreas, and/or digestive organ) (4)Subjects who have hypertension (not less than level 3) (5)Subjects who continuously use anti-inflammatory agent or muscle relaxant (6)Subjects who continuously use pack and/or topical cream etc. on knee and/or leg region (7)Subjects who continuously use medicines and/or Chinese herbal medicine, and can't stop using during this trial (8)Subjects who use functional foods that have mitigation or treatment effect for joint pain (e.g., amino acid, protein, vitamin D, chondroitin, collagen, and/or glucosamine), and can't stop using during this trial (9)Subjects who have previous medical history of drug and/or food allergy (10)Subjects with excessive alcohol-drinking behaviors (11)Subjects who contract or are under treatment for psychiatric disorder (12)Subjects who have been enrolled in the other clinical trials within about last 1 month (13)Subjects who are judged as unsuitable for the trial by the investigator or subinvestigator for other reasons

Design outcomes

Primary

MeasureTime frame
Questionnaires(JKOM)

Secondary

MeasureTime frame
Physical examinations Blood test Urine test Questionnaires(VAS, bodily sensation)

Countries

Japan

Contacts

Public ContactMakoto ICHINOHE

CPCC Company Limited Plan sales department

cpcc-contact@cpcc.co.jp03-5927-3112

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026